Globalagliatin Hydrochloride

盐酸亚格拉汀

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGlobalagliatin Hydrochloride
Drug Alias NameSY-004LY-2608204
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucokinase activators
TargetsGlucokinase
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesSingapore +[9
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesEli Lilly And Company
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesEli Lilly And Company
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A